![Roche funds effort by Syapse to build software for measuring outcomes in precision oncology](https://cdn.cancerletter.com/media/2018/01/measure-web.png)
![Roche funds effort by Syapse to build software for measuring outcomes in precision oncology](https://cdn.cancerletter.com/media/2018/01/measure-web.png)
Cover Story
Free
By Matthew Bin Han Ong
Roche has teamed up with the precision medicine company Syapse to develop software for measuring health outcomes and economic impact of precision medicine.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills